SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

06 Nov 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 3108.44 millions as compared to Rs. 4177.49 millions during the year-ago period.Net Profit of the company move down -64.12% to Rs. 319.59  millions from Rs. 890.65 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 656.75 millions from 1403.46 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3108.44 4177.49 -25.59 7504.46 7807.43 -3.88 15585.80 11911.98 30.84
Other Income 43.32 30.48 42.13 91.39 50.87 79.65 125.44 97.48 28.68
PBIDT 656.75 1403.46 -53.20 1943.08 2396.50 -18.92 4744.65 2810.56 68.82
Interest 10.63 44.33 -76.02 37.34 66.47 -43.82 139.97 130.67 7.12
PBDT 646.12 1359.13 -52.46 2112.00 2330.03 -9.36 4604.68 2679.89 71.82
Depreciation 160.73 145.08 10.79 323.52 280.94 15.16 596.99 527.76 13.12
PBT 485.39 1214.05 -60.02 1788.48 2049.09 -12.72 4007.69 2152.13 86.22
TAX 165.80 323.40 -48.73 485.50 536.20 -9.46 1011.73 520.94 94.21
Deferred Tax 43.68 9.03 383.72 57.57 12.36 365.78 15.87 17.04 -6.87
PAT 319.59 890.65 -64.12 1302.98 1512.89 -13.87 2995.96 1631.19 83.67
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 21.13 33.60 -37.11 25.89 30.70 -15.65 30.44 23.59 29.02

Neuland Laboratories Share Price

14815.00 -116.45 (-0.78%)
22-Apr-2026 11:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.40
Dr. Reddys Lab 1219.15
Cipla 1230.95
Zydus Lifesciences 931.65
Lupin 2312.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×